ArticleJournal of molecular medicine (Berlin, Germany)2018

Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.

Svetlana Slavic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.